Rebate agreement for medicines containing promethazine

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing promethazine between DAK-Gesundheit and interested pharmaceutical companies. The agreement is intended to cover the supply of medicines with the specified active substance at the expense of statutory health insurance funds from 01/07/2026 to 30/06/2028, with a possible 12-month extension. The machine-readable notice did not include precise participation or compliance requirements; these must be checked in the tender documents.